Edited by Paolo A Ascierto, Francesco M Marincola and Nicolar Mozzillo.
Volume 14 Supplement 1
Melanoma and Immunotherapy Bridge 2015: meeting abstracts
Meeting abstracts
Publication charges for this supplement were funded by 3P Solution, Milan, Italy. PAA has acted in a consultant/advisory role for BMS, Roche-Genentech, MSD, Ventana, Novartis and Amgen and has received research funding from BMS, Roche-Genentech and Ventana. The other Supplement Editors declare that they have no competing interests.
Naples, Italy1-5 December 2015
Annual Journal Metrics
-
Speed
56 days to first decision for reviewed manuscripts only
51 days to first decision for all manuscripts
104 days from submission to acceptance
10 days from acceptance to publicationCitation Impact
4.098 - 2-year Impact Factor
4.301 - 5-year Impact Factor
1.133 - Source Normalized Impact per Paper (SNIP)
1.591 - SCImago Journal Rank (SJR)Usage
1,393,180 Downloads
2,714 Altmetric mentions
Advertisement
